BCLS II Investco (GP), LLC has an estimated net worth of $45 Million. This is based on reported shares across multiple companies, which include Xilio Therapeutics, Inc., Solid Biosciences Inc., and NewAmsterdam Pharma Co N.V..

2021 was BCLS II Investco (GP), LLC's most active year for acquiring shares with 4 total transactions. BCLS II Investco (GP), LLC's most active month to acquire stocks was the month of November. 2024 saw BCLS II Investco (GP), LLC paying a total of $44,999,840.03 for 2,536,813 shares, this is the most they've acquired in one year.